LIA
AVNS

LS Investment Advisors’s Avanos Medical AVNS Stock Holding History

LS Investment Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,621
Closed -$246K – 211
2021
Q1 		$246K Sell
5,621
-753
-12% -$35.3K 0.01% 666
2020
Q4 		$292K Buy
+6,374
New +$265K 0.02% 637
2020
Q3 		– Sell
-2,813
Closed -$83K – 855
2020
Q2 		$83K Buy
2,813
+135
+5% +$3.91K 0.01% 1039
2020
Q1 		$72K Buy
2,678
+5
+0.2% +$149 0.01% 1007
2019
Q4 		$90K Sell
2,673
-2,798
-51% -$101K ﹤0.01% 1141
2019
Q3 		$205K Buy
5,471
+107
+2% +$4.08K 0.01% 775
2019
Q2 		$234K Sell
5,364
-354
-6% -$15.1K 0.01% 707
2019
Q1 		$244K Buy
5,718
+59
+1% +$2.64K 0.02% 706
2018
Q4 		$253K Buy
5,659
+2,670
+89% +$140K 0.02% 658
2018
Q3 		$205K Sell
2,989
-79
-3% -$5.08K 0.01% 830
2018
Q2 		$176K Hold
3,068
– – 0.01% 925
2018
Q1 		$141K Sell
3,068
-391
-11% -$18.6K 0.01% 1003
2017
Q4 		$160K Sell
3,459
-611
-15% -$28.1K 0.01% 1006
2017
Q3 		$183K Buy
4,070
+53
+1% +$2.26K 0.01% 958
2017
Q2 		$158K Buy
4,017
+556
+16% +$21K 0.01% 980
2017
Q1 		$132K Sell
3,461
-131
-4% -$5.11K 0.01% 1023
2016
Q4 		$133K Buy
3,592
+124
+4% +$4.43K 0.01% 952
2016
Q3 		$120K Buy
3,468
+227
+7% +$7.95K 0.01% 952
2016
Q2 		$105K Buy
3,241
+661
+26% +$20.2K 0.01% 985
2016
Q1 		$74K Hold
2,580
– – 0.01% 991
2015
Q4 		$86K Hold
2,580
– – 0.01% 909
2015
Q3 		$73K Hold
2,580
– – 0.01% 985
2015
Q2 		$104K Buy
2,580
+1,763
+216% +$79.1K 0.01% 862
2015
Q1 		$40K Sell
817
-16
-2% -$741 ﹤0.01% 710
2014
Q4 		$38K Buy
+833
New +$32.7K ﹤0.01% 717

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

LS Investment Advisors's AVNS Position: Q2 2021 in Review

LS Investment Advisors sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 5,621 shares — an estimated $246K sold.

LS Investment Advisors first reported a position in AVNS in Q4 2014 and held it in 25 quarters. The position peaked at $292K in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • LS Investment Advisors reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 5,621 Avanos Medical shares in Q2 2021, an estimated $246K.
  • LS Investment Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 25 quarters.
  • LS Investment Advisors's Avanos Medical position peaked at $292K in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.